Partnering

We believe collaborating with leading and like-minded partners will create the best-in-class vaccines for patients. Our business model is geared toward a multi-partner approach focused around single or multiple vaccine target discovery, design and development agreements

Why work/collaborate with Evaxion?

At Evaxion, we stand at the forefront of the biotechnology industry with our advanced use of artificial intelligence and machine learning technologies to model the immune system. However, our strength lies not only in our technological innovations but also in our comprehensive, multidisciplinary approach. Our multidisciplinary team operates within state-of-the-art facilities to pioneer the design and development of personalized and precision vaccine candidates tailored to meet specific disease signatures and partners’ needs.

Our robust AI prediction models are specifically trained in the fields of cancer and infectious diseases, offering a clinically validated predictive capability that sets us apart in the biotech space. This precision allows for the rapid discovery of therapeutically relevant and delivery modality agnostic vaccine targets within 24 hours, enabling us to meet a wide range of specifications and requirements.

At Evaxion, we partner at various stages

Card Icon
Target discovery
Target discovery collaboration for novel cancer or infectious disease vaccines​
Card Icon
Pipeline
Partnership around existing cancer or infectious disease pipeline vaccine candidates​
Card Icon
Complementary antigens
Complementary AI-predicted antigens (B-cell or T cell antigens) for your current programs​

Partnership inquiries

If you would like to partner with Evaxion and our AI-Immunology™ powered vaccine discovery platform or have a technology with the potential to become an immunological treatment for a disease with an unmet medical need, we look forward to hearing from you:

We welcome inquiries about establishing new collaborations involving both preclinical and development-stage assets, as well as drug discovery and development technologies. We are actively exploring all approaches that may change the treatment of a serious disease where no adequate treatment currently exists.

    Inquiry type*
    Partnering/Business developmentInvestorMediaGeneral

    Submit partnership inquiry

      Inquiry type*
      Partnering/Business developmentInvestorMediaGeneral